Astrazeneca (AZN) Filings

SC TO-T/A

CINC CinCor Pharma Inc

3 Feb 23

Third party tender offer statement (amended)

5:21pm

6-K

AZN Astrazeneca plc

1 Feb 23

Total Voting Rights

11:23am

6-K

AZN Astrazeneca plc

26 Jan 23

Update on Evusheld Us Eua

1:42pm

SC 13G/A

AZN Astrazeneca plc

24 Jan 23

ASTRAZENECA / BlackRock ownership change

1:56pm

SC TO-T

AZN Astrazeneca plc

23 Jan 23

Third party tender offer statement

8:12am

6-K

AZN Astrazeneca plc

17 Jan 23

Acquisition of Neogene Therapeutics Completed

10:25am

6-K

AZN Astrazeneca plc

11 Jan 23

Airsupra (PT027) Approved In Us for Asthma

8:57am

SC TO-C

CINC CinCor Pharma Inc

9 Jan 23

Information about tender offer

4:30pm

6-K

AZN Astrazeneca plc

9 Jan 23

Astrazeneca Acquire Cincor for Cardiorenal Asset

8:15am

6-K

AZN Astrazeneca plc

3 Jan 23

Total Voting Rights

11:08am

6-K

AZN Astrazeneca plc

30 Dec 22

Director/pdmr Shareholding

7:12am

6-K

AZN Astrazeneca plc

28 Dec 22

Calquence Japan Approval for Treatment-naive CLL

6:43am

6-K

AZN Astrazeneca plc

28 Dec 22

Imfinzi, Imjudo Approved In Japan for 3 Cancers

6:25am

6-K

AZN Astrazeneca plc

21 Dec 22

Imfinzi Approved In Eu for Biliary Tract Cancer

6:36am

6-K

AZN Astrazeneca plc

21 Dec 22

Lynparza Approved In Eu for Prostate Cancer

6:22am

6-K

AZN Astrazeneca plc

19 Dec 22

Enhertu Recommended for Approval In the Eu by CHMP for Patients with HER2-LOW Metastatic Breast Cancer

8:49am

6-K

AZN Astrazeneca plc

19 Dec 22

Enhertu Approved In the Eu for Patients with Previously Treated HER2-POSITIVE Advanced Gastric Cancer

8:23am

6-K

AZN Astrazeneca plc

19 Dec 22

Imfinzi Plus Imjudo Recommended for Approval In the Eu by CHMP for the Treatment of Advanced Liver and Lung Cancers

7:04am

6-K

AZN Astrazeneca plc

19 Dec 22

Update on Pearl Phase III Trial of Imfinzi Monotherapy In Stage IV Non-small Cell Lung Cancer

6:52am

6-K

AZN Astrazeneca plc

19 Dec 22

Forxiga CHMP Opinion for Symptomatic Chronic HF

6:42am